Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021
This report describes an increase in Delta variant cases of COVID-19 in Mesa County, Colorado.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425571

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021
ACIP reviewed information on COVID-19 vaccines and concluded that benefits of vaccination outweigh the risks of rare, serious adverse events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425616

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021
The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422061

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021
On January 24, the Colorado Department of Public Health and Environment (CDPHE) identified the first Colorado case of COVID-19 attributed to the B.1.427 and B.1.429 variants. To improve convenience sampling to identify and track emerging variants, CDPHE established a 30-site statewide sentinel surveillance system.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421658

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021
This report describes COVID-19 outbreaks associated with large public gatherings in Massachusetts.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425231

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021
This report describes COVID-19 vaccine safety among U.S. adolescents aged 12-17 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425230

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021
This report describes an investigation in Maryland of two linked clusters of COVID-19 cases identified as the B.1.351 variant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421458

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539

25 Şubat 2022, Cuma, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421438